Learning Objectives:

• Differentiate between each new and emerging biologic treatment for CRSwNP using data from clinical trials and other analyses 
• Incorporate a patient-centric focus into evaluating the physical, extranasal, and psychosocial aspects of disease burden for each CRSwNP patient                                                                
• Elucidate best practices criteria for recommending sinus surgery or biologic therapy and when systemic corticosteroids may or may not be appropriate 
  
  

Faculty Panel:

Joseph K. Han, MD

Professor of Medicine 

Chief, Division of Rhinology & Endoscopic  

Sinus and Skull Base Surgery 

Eastern Virginia Medical School 

Norfolk, Virginia 

Anju T. Peters, MD

Professor of Medicine

Director of Clinical Research

Division of Allergy/Immunology and

Otolaryngology

Feinberg School of Medicine​

Northwestern University​

Chicago, Illinois 

Bruce K. Tan, MD

Associate Professor of Otolaryngology ​

Head and Neck Surgery and ​

Allergy-Immunology​

Feinberg School of Medicine​

Northwestern University​

Chicago, Illinois 

This activity is provided by Integrity Continuing Education, Inc.

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.

For participation in this program, attendees will be able to receive a maximum of 1.0 AMA PRA Category 1 CME credit™.

REGISTER HERE: https://integrityce.com/events/on-the-case-an-expert-panel-challenge-for-the-management-of-difficult-cases-of-crswnp-livestream/